File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3969/j.issn.1674-8115.2020.04.005
- Scopus: eid_2-s2.0-85086086860
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Quantification of human plasma 7α-hydroxy-4-cholesten-3-one and bile acids by UPLC-MS/MS
Title | Quantification of human plasma 7α-hydroxy-4-cholesten-3-one and bile acids by UPLC-MS/MS |
---|---|
Authors | |
Keywords | 7α-hydroxy-4-cholesten-3-one (C4) Chenodeoxycholic acid (CDCA) Cholic acid (CA) Quantification UPLC-MS/MS |
Issue Date | 2020 |
Citation | Journal of Shanghai Jiaotong University (Medical Science), 2020, v. 40, n. 4, p. 443-449 How to Cite? |
Abstract | Objective : To develop a quantitative method of 7α-hydroxy-4-cholesten-3-one (C4), cholic acid (CA) and chenodeoxycholic acid (CDCA) in human plasma. Methods ¡¤ After extraction of C4, CA and CDCA with acetonitrile from plasma, they were quantified with stand-ard curve corrected by the internal standards based on Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results ¡¤ The limits of detection (LOD) of C4, CA and CDCA were 0.16, 0.02 and 0.04 nmol/L respectively; All three metabolites had good linear relationships (correlation coefficients R2 were over than 0.998). The relative standard deviations (RSDs) of repeatabilities were below 3.0%. The RSDs of inter-day and intra-day precision were less than 6%, and the RSDs of stabilities at 4 °C were below 10% within 7 days. The average added recoveries of C4, CA and CDCA were 97.7%, 113.3% and 105.0%, respectively. Conclusion ¡¤ This method is of high detective sensi-tivity, good precision and stability, which meets the quantitative requirements of plasma biological samples. |
Persistent Identifier | http://hdl.handle.net/10722/342246 |
ISSN | 2023 SCImago Journal Rankings: 0.110 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ge, Kun | - |
dc.contributor.author | Qu, Chun | - |
dc.contributor.author | Jia, Wei | - |
dc.contributor.author | Zhao, Ai Hua | - |
dc.date.accessioned | 2024-04-17T07:02:24Z | - |
dc.date.available | 2024-04-17T07:02:24Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Journal of Shanghai Jiaotong University (Medical Science), 2020, v. 40, n. 4, p. 443-449 | - |
dc.identifier.issn | 1674-8115 | - |
dc.identifier.uri | http://hdl.handle.net/10722/342246 | - |
dc.description.abstract | Objective : To develop a quantitative method of 7α-hydroxy-4-cholesten-3-one (C4), cholic acid (CA) and chenodeoxycholic acid (CDCA) in human plasma. Methods ¡¤ After extraction of C4, CA and CDCA with acetonitrile from plasma, they were quantified with stand-ard curve corrected by the internal standards based on Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results ¡¤ The limits of detection (LOD) of C4, CA and CDCA were 0.16, 0.02 and 0.04 nmol/L respectively; All three metabolites had good linear relationships (correlation coefficients R2 were over than 0.998). The relative standard deviations (RSDs) of repeatabilities were below 3.0%. The RSDs of inter-day and intra-day precision were less than 6%, and the RSDs of stabilities at 4 °C were below 10% within 7 days. The average added recoveries of C4, CA and CDCA were 97.7%, 113.3% and 105.0%, respectively. Conclusion ¡¤ This method is of high detective sensi-tivity, good precision and stability, which meets the quantitative requirements of plasma biological samples. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Shanghai Jiaotong University (Medical Science) | - |
dc.subject | 7α-hydroxy-4-cholesten-3-one (C4) | - |
dc.subject | Chenodeoxycholic acid (CDCA) | - |
dc.subject | Cholic acid (CA) | - |
dc.subject | Quantification | - |
dc.subject | UPLC-MS/MS | - |
dc.title | Quantification of human plasma 7α-hydroxy-4-cholesten-3-one and bile acids by UPLC-MS/MS | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3969/j.issn.1674-8115.2020.04.005 | - |
dc.identifier.scopus | eid_2-s2.0-85086086860 | - |
dc.identifier.volume | 40 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 443 | - |
dc.identifier.epage | 449 | - |